Author: pallavi123

Lupin Limited launches Generic Suprep Bowel Prep Kit in the US

pallavi123- September 20, 2022

Indian pharma company Lupin Limited has launched Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution, 17.5 g/3.13 g/1.6 g per 6 ounces, after getting ... Read More

Zydus Lifesciences launches Revlimid generic – Lenalidomide Capsules in US

pallavi123- September 20, 2022

Indian pharma company Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited has launched Lenalidomide Capsules, a generic of Revlimid, in the US market. The ... Read More

RattanIndia announces launch of Throttle Aerospace Systems’ Defender drone

pallavi123- September 20, 2022

Indian conglomerate RattanIndia Enterprises Ltd. (REL) has announced the launch of an advanced ‘Made in India’ drone called ‘Defender’ through its subsidiary Throttle Aerospace Systems ... Read More

HCL Technologies to launch InFusion THoR hospitality management solution

pallavi123- September 19, 2022

HCL Technologies said that it will launch InFusion THoR, a touchless hospitality and reservations solution at Dreamforce 2022 to be held in San Francisco from ... Read More

Zydus Lifesciences gets tentative FDA approval for Sugammadex generic

pallavi123- September 18, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for Sugammadex Injection USP 200 mg/2 mL (100 ... Read More

Centessa Pharmaceuticals gets FDA orphan drug status for SerpinPC in hemophilia B

pallavi123- September 17, 2022

Centessa Pharmaceuticals has secured orphan drug designation from the US Food and Drug Administration (FDA) for SerpinPC in hemophilia B treatment. According to the UK-based ... Read More

Zydus Lifesciences bags FDA approval for Cariprazine generic

pallavi123- September 17, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary — Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration ... Read More

US FDA issues Form 483 to Alkem Laboratories for St Louis plant

pallavi123- September 16, 2022

Alkem Laboratories said that it has been issued Form 483 with a couple of observations from the US Food and Drug Administration (FDA) pertaining to ... Read More

Bharat Forge, Harbinger Motors to develop electric powertrains for trucks

pallavi123- September 14, 2022

Kalyani Powertrain, a wholly owned subsidiary of Indian automotive forging company Bharat Forge, is set to create a joint venture (JV) with Harbinger Motors, a ... Read More

Lupin secures Health Canada approval for Enbrel biosimilar – Rymti

pallavi123- September 13, 2022

Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor of tumour necrosis factor (TNF). Rymti is ... Read More